Fixed dose comparison of escitalopram combination in adult patients with major depressive disorder.

Trial Profile

Fixed dose comparison of escitalopram combination in adult patients with major depressive disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Mar 2012

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors Forest Laboratories
  • Most Recent Events

    • 02 Mar 2012 Actual end date (1 Nov 2006) added as reported by ClinicalTrials.gov. (NCT00109044)
    • 02 Mar 2012 Actual end date (1 Nov 2006) added as reported by ClinicalTrials.gov. (NCT00109044)
    • 22 Dec 2007 Status change from in progress to completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top